Risk of second primary malignancies (SPM) following radioactive I-131 (RAI) therapy in patients with differentiated thyroid cancer (DTC)

被引：0
|
作者：
Ansari, Aiysha [1 ]
Kulkarni, Kanchan [1 ]
Van Nostrand, Douglas [1 ]
Khorjekarand, Gauri [1 ]
Garcia, Carlos [1 ]
机构：
[1] WHC, Nucl Med, Washington, DC USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2010年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1084
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Risk of second primary cancer following differentiated thyroid cancer
    Emmanuelle Berthe
    Michel Henry-Amar
    Jean-Jacques Michels
    Jean-Pierre Rame
    Pascaline Berthet
    Emmanuel Babin
    Philippe Icard
    Guy Samama
    Françoise Galateau-Sallé
    Jacques Mahoudeau
    Stéphane Bardet
    European Journal of Nuclear Medicine and Molecular Imaging, 2004, 31 : 685 - 691
  • [22] Risk of second primary cancer following differentiated thyroid cancer
    Berthe, E
    Henry-Amar, M
    Michels, JJ
    Rame, JP
    Berthet, P
    Babin, E
    Icard, P
    Samama, G
    Galateau-Sallé, F
    Mahoudeau, J
    Bardet, S
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (05) : 685 - 691
  • [23] EFFECTIVE RADIATION-DOSE OF I-131 THERAPY FOR DIFFERENTIATED PRIMARY OR RECURRENT THYROID-CANCER
    HEIKKONEN, J
    ARONEN, H
    PYRHONEN, S
    RADIOACTIVE ISOTOPES IN CLINICAL MEDICINE AND RESEARCH /, 1988, : 381 - 385
  • [24] I-131 Radiation-Induced Myelosuppression in Differentiated Thyroid Cancer Therapy
    Probst, Stephan
    Abikhzer, Gad
    Chausse, Guillaume
    Tamilia, Michael
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2018, 27 (02) : 84 - 87
  • [25] CHRONIC MYELOID-LEUKEMIA FOLLOWING RADIOACTIVE IODINE I-131 THERAPY OF THYROID-CANCER
    HEGDE, UP
    GOPAL, R
    NANJANGUD, G
    ADVANI, SH
    LEUKEMIA & LYMPHOMA, 1991, 5 (2-3) : 215 - 217
  • [26] Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy
    Hong, Chae Moon
    Ahn, Byeong-Cheol
    FRONTIERS IN ENDOCRINOLOGY, 2017, 8
  • [27] Prognostic implications of diffuse hepatic uptake following I-131 therapy for differentiated thyroid cancer.
    Nakayama, Michihiro
    Okizaki, Atsutaka
    Sakaguchi, Miki
    Uno, Takahiro
    Ishitoya, Shunta
    Sato, Junichi
    Takahashi, Koji
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [28] I-123 scan compared to post-therapy I-131 scan for the detection of remnant or metastasis of differentiated thyroid cancer (DTC)
    Alnafisi, N
    Delfyett, W
    Yun, M
    Alavi, A
    Mandel, S
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1022 - 1022
  • [29] Depression in thyroid cancer patients receiving I-131 therapy
    Sioka, C.
    Giotakos, O.
    Dimakopoulos, N.
    Fourlis, S.
    Zouboulidis, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S292 - S292
  • [30] I-131 uptake augmentation by thiazide diuretics in differentiated thyroid cancer patients
    Sayman, HB
    Senmevsim, O
    Kanmaz, B
    Mete, C
    Sager, S
    Onsel, C
    Sonmezoglu, K
    Kabasakal, L
    Uslu, I
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S466 - S466
12345